Rheumatologists’ Disease-modifying Antirheumatic Drug Preferences for Rheumatoid Arthritis: Results from a Survey in Nigeria
Annals of African Medicine · 2026
DOI: 10.4103/aam.aam_98_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of African Medicine, 2026. Verfasst von Celestine Chibuzo Okwara und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, College of Medicine, University of Nigeria, Ituku-Ozalla Campus, Enugu, Nigeria. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents, Practice Patterns, Physicians', Rheumatologists. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
There are regional differences in rheumatoid arthritis (RA) disease-modifying antirheumatic drug (DMARD) use and availability. These stem from factors and peculiarities in population characteristics and socioeconomic indices. There is no published literature on the DMARD preferences or prescription patterns in Nigeria. The aim of this study was to document the prescription pattern of DMARD in Nigeria as well as factors affecting the choice of DMARD among Nigerian rheumatologists and establish a documentary evidence of what the real-life prescription pattern is in a low-middle income country for the treatment of RA.
Methods
Online survey using pretested structured questionnaire inputted on the SurveyMonkey App and its link sent to and answers received from practicing Nigeria consultant rheumatologists. Analysis of data was done using data exported to SPSS.
Results
A total of 26 (63.4%) responses from consultant rheumatologists in Nigeria were received. Most participants (84.62% [22]) had their place of practice at a teaching hospital. The initial choice of DMARD monotherapy was methotrexate (MTX) (88.5%), followed by sulphasalazine (11.5%). Cost of medications, need for rapid disease control, and presence of joint erosions were the most common reasons that influenced rheumatologists’ choice of DMARDs. Prescription rate of biologic DMARDs (bDMARDs) was low.
Conclusion
MTX remains the DMARD of first choice for RA among Nigerian rheumatologists. Conventional synthetic DMARDs are the commonly available, widely used, and still effective armamentarium for RA in resource-poor settings like Nigeria. bDMARDs prescription rate for RA remains low in Nigeria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, College of Medicine, University of Nigeria, Ituku-Ozalla Campus, Enugu, Nigeria.
- Department of Medicine, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria.
- Department of Medicine, Enugu State University of Science and Technology, Enugu, Nigeria.
Zitieren
APA
Okwara, C. C., Mbadiwe, N. C., Ezeala-Adikaibe, B., Onu, U. C., Abonyi, M., Ekochin, F., Ndionuka, I., Adiri, W. N., Onodugo, N. P., & Onwuchekwa, I. (2026). Rheumatologists’ Disease-modifying Antirheumatic Drug Preferences for Rheumatoid Arthritis: Results from a Survey in Nigeria. Annals of African Medicine. https://doi.org/10.4103/aam.aam_98_25
Vancouver
Okwara CC, Mbadiwe NC, Ezeala-Adikaibe B, Onu UC, Abonyi M, Ekochin F, et al. Rheumatologists’ Disease-modifying Antirheumatic Drug Preferences for Rheumatoid Arthritis: Results from a Survey in Nigeria. Annals of African Medicine. 2026. doi:10.4103/aam.aam_98_25
BibTeX
@article{Okwara2026,
author = {Okwara, Celestine Chibuzo and Mbadiwe, Nkeiruka Chigekwu and Ezeala-Adikaibe, Birinus and Onu, Ugochi Chika and Abonyi, Michael and Ekochin, Fintan and Ndionuka, Ijeoma and Adiri, Winifred Njideka and Onodugo, Nkiruka Pauline and Onwuchekwa, Ijeoma},
title = {Rheumatologists’ Disease-modifying Antirheumatic Drug Preferences for Rheumatoid Arthritis: Results from a Survey in Nigeria},
journal = {Annals of African Medicine},
year = {2026},
doi = {10.4103/aam.aam_98_25}
}
EUVIMED